Long non-coding RNA DLX6-AS1 is the key mediator of glomerular podocyte injury and albuminuria in diabetic nephropathy by targeting the miR-346/GSK-3β signaling pathway.

Long non-coding RNA DLX6-AS1 is the key mediator of glomerular podocyte injury and albuminuria in diabetic nephropathy by targeting the miR-346/GSK-3β signaling pathway.
复制标题

长链非编码 RNA DLX6-AS1 通过靶向 miR-346/GSK-3β 信号通路,成为糖尿病肾病肾小球足细胞损伤和蛋白尿的关键介质。

DOI:
10.1038/s41419-023-05695-2
复制
发表时间:
2023-02-28
影响因子:
9
通讯作者:
Liu, Zhangsuo
Liu, Zhangsuo
中科院分区:
生物学1区
文献类型:
--
作者:
Guo, Jia;Zheng, Wen;Liu, Yong;Zhou, Mengwen;Shi, Yan;Lei, Min;Zhang, Chaojie;Liu, Zhangsuo

文献摘要

参考文献

相似文献

Progressive albuminuria is the primary clinical symptom of diabetic nephropathy (DN), leading to a gradual decline in kidney function. DLX6-AS1 was the first reported long non-coding RNA (lncRNA) to participate in organogenesis and play crucial roles in the brain or neural cell development. Herein, we investigated the DLX6-AS1 (Dlx6-os1 in mice) role in DN pathogenesis. We found that DLX6-AS1 expression in DN patients correlated with the extent of albuminuria. Dlx6-os1 overexpression induced cellular damage and inflammatory responses in cultured podocytes through miR-346-mediated regulation of the GSK-3β pathway. In various established diabetic and newly developed knockout mouse models, Dlx6-os1 knockdown/knockout significantly reduced podocyte injury and albuminuria. The Dlx6-os1 effects were remarkably modulated by miR-346 mimics or mutants and significantly diminished in podocyte-specific GSK-3β-knockout mice. Thus, DLX6-AS1 (Dlx6-os1) promotes DN development by accelerating podocyte injury and inflammation through the upregulation of the GSK-3β pathway, providing a novel molecular target for DN therapy.
DOI: 10.1038/s41419-021-03709-5
发表时间: 2021-04-30
影响因子: 9
作者:
Chen B;Wang P;Liang X;Jiang C;Ge Y;Dworkin LD;Gong R
通讯作者: Gong R
LncRNA SNHG17 敲低促进 Parkin 依赖性线粒体自噬并通过 Mst1 减少足细胞凋亡
DOI: 10.1080/15384101.2020.1783481
发表时间: 2020-07-06
期刊: CELL CYCLE
影响因子: 4.3
作者:
Guo, Feng;Wang, Weimin;Qin, Guijun
通讯作者: Qin, Guijun
DOI: 10.1186/s12935-019-1010-z
发表时间: 2019-11-26
影响因子: 5.8
作者:
Guo, Jinan;Chen, Zhixin;Xiao, Kefeng
通讯作者: Xiao, Kefeng
DOI: 10.1016/j.pediatrneurol.2016.03.020
发表时间: 2016-09-01
影响因子: 3.8
作者:
Al Teneiji, Amal;Siriwardena, Komudi;Mercimek-Mahmutoglu, Saadet
通讯作者: Mercimek-Mahmutoglu, Saadet
DOI: 10.2147/cmar.s237181
发表时间: 2020-01-01
影响因子: 3.3
作者:
Liu, Yan;Liu, Xinyi;Xing, Hao
通讯作者: Xing, Hao